Patents by Inventor Franziska ZABEL

Franziska ZABEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11571474
    Abstract: The present invention relates to the use of a composition in a method of reducing the allergenicity of a cat. Moreover, the present invention relates to the use of a composition in a method of reducing the allergenicity of a cat for a human exposed to the cat. Furthermore, the present invention relates to compositions comprising a virus-like particle (VLP) and at least one Fel d1 protein. The compositions of the invention induce efficient immune responses, in particular antibody responses, in cats and are useful for the treatment and/or prevention of cat allergy.
    Type: Grant
    Filed: October 13, 2020
    Date of Patent: February 7, 2023
    Assignee: UNIVERSITÄT ZÜRICH
    Inventors: Martin Bachmann, Gary Jennings, Thomas Kündig, Gabriela Senti, Franziska Zabel
  • Publication number: 20210106676
    Abstract: The present invention relates to the use of a composition in a method of reducing the allergenicity of a cat. Moreover, the present invention relates to the use of a composition in a method of reducing the allergenicity of a cat for a human exposed to the cat. Furthermore, the present invention relates to compositions comprising a virus-like particle (VLP) and at least one Fel d1 protein. The compositions of the invention induce efficient immune responses, in particular antibody responses, in cats and are useful for the treatment and/or prevention of cat allergy.
    Type: Application
    Filed: October 13, 2020
    Publication date: April 15, 2021
    Inventors: Martin BACHMANN, Gary JENNINGS, Thomas KÜNDIG, Gabriela SENTI, Franziska ZABEL
  • Patent number: 10835600
    Abstract: The present invention relates to the use of a composition in a method of reducing the allergenicity of a cat. Moreover, the present invention relates to the use of a composition in a method of reducing the allergenicity of a cat for a human exposed to the cat. Furthermore, the present invention relates to compositions comprising a virus-like particle (VLP) and at least one Fel d1 protein. The compositions of the invention induce efficient immune responses, in particular antibody responses, in cats and are useful for the treatment and/or prevention of cat allergy.
    Type: Grant
    Filed: September 7, 2016
    Date of Patent: November 17, 2020
    Assignee: UNIVERSITÄT ZÜRICH
    Inventors: Martin Bachmann, Gary Jennings, Thomas Kündig, Gabriela Senti, Franziska Zabel
  • Publication number: 20180250387
    Abstract: The present invention relates to the use of a composition in a method of reducing the allergenicity of a cat. Moreover, the present invention relates to the use of a composition in a method of reducing the allergenicity of a cat for a human exposed to the cat. Furthermore, the present invention relates to compositions comprising a virus-like particle (VLP) and at least one Fel d1 protein. The compositions of the invention induce efficient immune responses, in particular antibody responses, in cats and are useful for the treatment and/or prevention of cat allergy.
    Type: Application
    Filed: September 7, 2016
    Publication date: September 6, 2018
    Inventors: Martin BACHMANN, Gary JENNINGS, Thomas KÜNDIG, Gabriela SENTI, Franziska ZABEL